Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)

The rise in the incidence of nonalcoholic steatohepatitis (NASH) has necessitated the development of an effective prevention methodology. An antidiabetic drug, belonging to the group of sodium glucose cotransporter 2 (SGLT2) inhibitors, has been tested for its therapeutic effect on NASH; however, no...

Descripción completa

Detalles Bibliográficos
Autores principales: Goto, Ryo, Kamimura, Kenya, Shinagawa‐Kobayashi, Yoko, Sakai, Norihiro, Nagoya, Takuro, Niwa, Yusuke, Ko, Masayoshi, Ogawa, Kohei, Inoue, Ryosuke, Yokoo, Takeshi, Sakamaki, Akira, Kamimura, Hiroteru, Abe, Satoshi, Nishina, Hiroshi, Terai, Shuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443870/
https://www.ncbi.nlm.nih.gov/pubmed/30984539
http://dx.doi.org/10.1002/2211-5463.12598

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6443870/
https://www.ncbi.nlm.nih.gov/pubmed/30984539
http://dx.doi.org/10.1002/2211-5463.12598

Ejemplares similares